Literature DB >> 2548096

Human parvovirus B19 infection among hospital staff members after contact with infected patients.

L M Bell1, S J Naides, P Stoffman, R L Hodinka, S A Plotkin.   

Abstract

In the spring and summer of 1988, two separate outbreaks of an illness with a rash resembling erythema infectiosum occurred among members of the nursing staff of the Children's Hospital of Philadelphia. The sources were two adolescent patients with sickle cell disease and aplastic crisis who had unsuspected parvovirus infection. Tests for IgM and IgG antibodies to parvovirus B19 were positive in both patients, and electron microscopical examination showed parvovirus-like particles in the early serum samples. Of 40 health care workers exposed to infected patients, 12 (30 percent) were infected, 2 (5 percent) were possibly infected, 8 (20 percent) had evidence of a past infection with B19, and 18 (45 percent) remained seronegative. Attack rates among the susceptible contacts were 36 percent in the first outbreak and at least 38 percent in the second. Clinical symptoms began a mean of 12.6 days after exposure and included malaise, rash, and joint pain. We conclude that hospital workers are at risk of contracting nosocomial erythema infectiosum from patients with parvovirus-associated aplastic crisis. We recommend that all patients with hereditary hemolytic anemias who are admitted with a febrile illness be evaluated for aplasia and promptly placed in respiratory and contact isolation if aplastic crisis is suspected.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548096     DOI: 10.1056/NEJM198908243210801

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  16 in total

Review 1.  Nosocomial spread of viral disease.

Authors:  C Aitken; D J Jeffries
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy.

Authors:  Sung-Hsin Kuo; Liang-In Lin; Chee-Jen Chang; Yun-Ru Liu; Kuo-Sin Lin; Ann-Lii Cheng
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Human parvovirus B19 infection within a family and risk for pregnant women.

Authors:  A Azzi; M Trotta; K Zakrzewska; E Balzer; P G Rogasi; A Carocci; F Leoncini
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

4.  Seroprevalence of human parvovirus B19 in healthy blood donors.

Authors:  Satish Kumar; R M Gupta; Sourav Sen; R S Sarkar; J Philip; Atul Kotwal; S H Sumathi
Journal:  Med J Armed Forces India       Date:  2013-02-23

5.  Parvovirus infection causing red cell aplasia and leukopenia in rheumatoid arthritis.

Authors:  A M Kamper; M Malbrain; P Zachee; S L Chew
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

Review 6.  Erythema infectiosum and pregnancy-related complications.

Authors:  M Levy; S E Read
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

Review 7.  Parvovirus B19 infection.

Authors:  J R Kerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

8.  Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19.

Authors:  E Fridell; B J Cohen; B Wahren
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

Review 9.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

10.  Parvovirus B19 outbreak on an adult ward.

Authors:  C Seng; P Watkins; D Morse; S P Barrett; M Zambon; N Andrews; M Atkins; S Hall; Y K Lau; B J Cohen
Journal:  Epidemiol Infect       Date:  1994-10       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.